Data as of May 17
| +0.71 / +1.67%|
The 18 analysts offering 12-month price forecasts for Metlife Inc have a median target of 46.00, with a high estimate of 55.00 and a low estimate of 41.00. The median estimate represents a +6.28% increase from the last price of 43.28.
The current consensus among 23 polled investment analysts is to Buy stock in Metlife Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.